Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1Breast 1

Conditions

Carcinoma, Renal Cell 3Melanoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Radiotherapy 4Docetaxel 4Trastuzumab 3Psychiatric Rehabilitation 3cediranib 2Therapeutics 2Standard of Care 2Radiosurgery 2Physical Therapy Modalities 2Early Intervention, Educational 2Cyclophosphamide 2vandetanib 1tipifarnib 1temsirolimus 1sargramostim 1palbociclib 1orantinib 1interleukin-4-Pseudomonas exotoxin 1entinostat 1X-Ray Therapy 1Watchful Waiting 1Vorinostat 1Vinorelbine 1Thiotepa 1Thalidomide 1Sirolimus 1Practice Guidelines as Topic 1Phlebotomy 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × Decitabine × Genitourinary × Clear all
NCT00030615 2013-02-07

Decitabine in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
24 enrolled
BreastDermatologicGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Melanoma, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡